SPY344.61+1.88 0.55%
DIA283.65+1.68 0.60%
IXIC11,506.01+21.31 0.19%

Morgan Stanley Maintains Equal-Weight on Global Blood Therapeutics, Lowers Price Target to $68

Morgan Stanley maintains Global Blood Therapeutics (NASDAQ:GBT) with a Equal-Weight and lowers the price target from $75 to $68.

· 10/13/2020 09:41
Morgan Stanley maintains Global Blood Therapeutics (NASDAQ:GBT) with a Equal-Weight and lowers the price target from $75 to $68.